• Je něco špatně v tomto záznamu ?

A "cute" desensitization of TRPV1

F. Touska, L. Marsakova, J. Teisinger, V. Vlachova,

. 2011 ; 12 (1) : 122-9.

Jazyk angličtina Země Nizozemsko

Typ dokumentu časopisecké články, práce podpořená grantem, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc12027958

Capsaicin and other vanilloids selectively excite and subsequently desensitize pain-conducting nerve fibers (nociceptors) and this process contributes to the analgesic (and thus therapeutically relevant) effects of these compounds. Such a desensitization process is triggered by the activation of the transient receptor potential vanilloid subtype 1 receptor channels (TRPV1) that open their cationic pores, permeable to sodium, potassium and calcium (Ca(2+)) ions. Depending on the duration of capsaicin exposure and the external calcium concentration, the Ca(2+) influx via TRPV1 channels desensitizes the channels themselves, which, from the cellular point of view, represents a feedback mechanism protecting the nociceptive neuron from toxic Ca(2+) overload. The 'acute desensitization' accounts for most of the reduction in responsiveness occurring within the first few (~20) seconds after the vanilloids are administered to the cell for the first time. Another form of desensitization is 'tachyphylaxis', which is a reduction in the response to repeated applications of vanilloid. The wealth of pathways following TRPV1 activation that lead to increased intracellular Ca(2+) levels and both forms of desensitization is huge and they might utilise just about every known type of signalling molecule. This review will not attempt to cover all historical aspects of research into all these processes. Instead, it will try to highlight some new challenging thoughts on the important phenomenon of TRPV1 desensitization and will focus on the putative mechanisms that are thought to account for the acute phase of this process.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc12027958
003      
CZ-PrNML
005      
20160211100424.0
007      
ta
008      
120817s2011 ne f 000 0#eng||
009      
AR
024    7_
$a 10.2174/138920111793937826 $2 doi
035    __
$a (PubMed)20932251
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Touška, Filip $7 xx0121543 $u Department of Cellular Neurophysiology, Institute of Physiology, Academy of Sciences of the Czech Republic, Videnska 1083, 142 20 Prague 4, Czech Republic.
245    13
$a A "cute" desensitization of TRPV1 / $c F. Touska, L. Marsakova, J. Teisinger, V. Vlachova,
520    9_
$a Capsaicin and other vanilloids selectively excite and subsequently desensitize pain-conducting nerve fibers (nociceptors) and this process contributes to the analgesic (and thus therapeutically relevant) effects of these compounds. Such a desensitization process is triggered by the activation of the transient receptor potential vanilloid subtype 1 receptor channels (TRPV1) that open their cationic pores, permeable to sodium, potassium and calcium (Ca(2+)) ions. Depending on the duration of capsaicin exposure and the external calcium concentration, the Ca(2+) influx via TRPV1 channels desensitizes the channels themselves, which, from the cellular point of view, represents a feedback mechanism protecting the nociceptive neuron from toxic Ca(2+) overload. The 'acute desensitization' accounts for most of the reduction in responsiveness occurring within the first few (~20) seconds after the vanilloids are administered to the cell for the first time. Another form of desensitization is 'tachyphylaxis', which is a reduction in the response to repeated applications of vanilloid. The wealth of pathways following TRPV1 activation that lead to increased intracellular Ca(2+) levels and both forms of desensitization is huge and they might utilise just about every known type of signalling molecule. This review will not attempt to cover all historical aspects of research into all these processes. Instead, it will try to highlight some new challenging thoughts on the important phenomenon of TRPV1 desensitization and will focus on the putative mechanisms that are thought to account for the acute phase of this process.
650    _2
$a analgetika $x metabolismus $x farmakologie $7 D000700
650    _2
$a zvířata $7 D000818
650    _2
$a vápník $x metabolismus $7 D002118
650    _2
$a kapsaicin $x metabolismus $x farmakologie $7 D002211
650    _2
$a lidé $7 D006801
650    _2
$a nociceptory $x metabolismus $7 D009619
650    _2
$a fosfolipasa C fosfoinositidové signalizace $x metabolismus $7 D054801
650    _2
$a fosforylace $7 D010766
650    _2
$a kationtové kanály TRPV $x agonisté $x metabolismus $7 D050916
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
655    _2
$a přehledy $7 D016454
700    1_
$a Maršáková, Lenka. $7 _AN066948
700    1_
$a Teisinger, Jan, $d 1944- $7 xx0088476
700    1_
$a Vlachová, Viktorie, $d 1958- $7 xx0030589
773    0_
$w MED00007892 $t Current pharmaceutical biotechnology $x 1873-4316 $g Roč. 12, č. 1 (2011), s. 122-9
856    41
$u https://pubmed.ncbi.nlm.nih.gov/20932251 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y m $z 0
990    __
$a 20120817 $b ABA008
991    __
$a 20160211100604 $b ABA008
999    __
$a ok $b bmc $g 950000 $s 785304
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2011 $b 12 $c 1 $d 122-9 $i 1873-4316 $m Current pharmaceutical biotechnology $n Curr Pharm Biotechnol $x MED00007892
LZP    __
$a Pubmed-20120817/11/03

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...